Rockefeller Capital Management L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 115 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
270.0%0.00%
Q3 2022$1,000270.0%0.00%
Q2 2022$0270.0%0.00%
Q1 2022$0270.0%0.00%
Q4 2021$0270.0%0.00%
Q3 2021$0270.0%0.00%
Q2 2021$0270.0%0.00%
Q1 2021$0270.0%0.00%
Q4 2020$0
-100.0%
270.0%0.00%
Q3 2020$1,0000.0%270.0%0.00%
Q2 2020$1,000270.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders